past
decad
paradigm
shift
medicin
interest
move
diseasetreat
diseaseprevent
health
care
medic
care
evalu
accord
diagnosi
prevent
treatment
diseas
also
accord
enhanc
life
qualiti
mainten
health
use
nutrit
medicin
food
context
new
strategi
drug
discoveri
advanc
experiment
approach
import
modern
medicin
current
mainstream
pharmaceut
research
develop
still
concentr
singl
compound
biochem
biolog
candid
drug
lead
compound
aim
specif
target
associ
diseas
drug
discoveri
strategi
howev
seem
reach
bottleneck
becom
ever
time
consum
labour
intens
costli
develop
new
drug
tradit
western
medic
research
expect
singl
compound
chemic
confer
high
potenc
low
toxic
high
select
target
molecularcellular
target
diseas
howev
realiti
ideal
prove
hard
achiev
therefor
develop
drug
candid
variou
tradit
altern
complementari
medicin
receiv
increas
worldwid
attent
tu
drug
discoveri
transform
game
chanc
mass
screen
overdepend
bruteforc
new
highthroughput
technolog
patwardhan
mashelkar
better
understand
approach
adapt
varieti
approach
crossdisciplinari
learn
draw
tradit
wisdom
consid
mani
scientist
critic
make
signific
differ
schmid
smith
drug
discoveri
strategi
develop
base
systemat
modern
investig
complementari
altern
system
medicin
cam
orand
tradit
system
medicin
reemerg
attract
approach
mani
pharmacolog
pharmaceut
research
accord
definit
nation
center
complementari
altern
system
medicin
nccam
cam
group
divers
medic
healthcar
system
practic
product
gener
consid
part
convent
medicin
western
medicin
manski
wallerstedt
although
defin
cam
arduou
gener
categor
sever
group
includ
natur
product
mind
bodi
medicin
manipul
bodybas
practic
cam
practic
speak
broad
sens
cam
practic
may
also
includ
ancient
selfintegr
medic
system
ayurved
medicin
tradit
chines
medicin
tcm
estim
develop
world
popul
still
reli
primarili
cam
azaizeh
et
al
plant
materi
major
sourc
variou
therapeut
agent
cam
categori
natur
product
ayurved
medicin
tcm
fact
within
tcm
plantderiv
medicin
use
prevent
treatment
variou
diseas
document
systemat
way
five
millennia
lam
et
al
within
context
expect
spectrum
medicin
plant
long
histori
use
quickli
rerecogn
highli
valuabl
futur
drug
discoveri
develop
recent
comment
lam
et
al
tu
imbal
specif
immun
system
coordin
gener
known
involv
pathogenesi
variou
diseas
includ
infect
dermat
inflammatori
bowel
diseas
metabol
syndrom
cancer
spectrum
inflammationrel
diseas
mantovani
et
al
nestl
et
al
modul
immun
system
henc
consid
vital
approach
treatment
control
variou
immunerel
diseas
cho
ouchi
et
al
recent
advent
breakthrough
omic
technolog
system
biolog
experiment
approach
creat
new
era
investig
develop
novel
therapeut
drug
divers
diseas
system
especi
complex
immunerel
disord
technolog
approach
includ
variou
genom
proteom
metabolom
cellom
lipidom
phenom
approach
well
associ
bioinformat
scienc
databas
gener
phytomedicin
includ
phytoextract
subfract
deriv
partit
use
organ
solvent
system
isol
singl
phytocompound
phytochem
long
histori
medicin
use
believ
interact
multipl
target
confer
pharmacolog
physiolog
effect
cellular
tissu
organ
level
experiment
use
seem
suggest
may
rel
safe
increas
number
studi
shown
tradit
phytomedicin
confer
varieti
immunomodulatori
activ
recent
reveal
other
studi
hou
et
al
shyur
yang
process
discov
develop
phytocompound
immunomodulatori
agent
evalu
use
differ
experiment
approach
omic
platform
shown
fig
review
group
specif
medicin
herb
deriv
plant
extract
fraction
deriv
phytochem
studi
immunomodulatori
bioactiv
assess
potenti
immunomodulatori
andor
inflammationregulatori
therapeut
agent
function
genom
proteom
approach
use
character
bioactiv
outlin
employ
key
strategi
futur
applic
accompani
find
discuss
detail
implic
phytomedicin
research
contempl
immun
system
natur
uniqu
complex
network
protect
host
bodi
foreign
pathogen
stress
insult
result
ill
govern
variou
interconnect
pathway
inflamm
microbi
recognit
microbi
clearanc
cell
tissu
damag
death
wound
heal
homeostat
system
requir
welltim
interplay
multipl
immun
cell
type
crosstalk
specif
tissu
microenviron
maintain
immun
homeostasi
immun
system
vertebr
least
tradit
divid
two
type
innat
immun
adapt
immun
ullrich
vese
et
al
although
distinct
innat
adapt
immun
becom
intertwin
recent
studi
lanier
sun
play
critic
role
function
defenc
system
invas
microbi
pathogen
present
environ
also
provid
regulatori
system
control
normal
cell
turnov
elimin
damag
cell
tumour
cell
typic
innat
immun
consid
first
line
defenc
pathogen
bacteria
virus
fungi
exhibit
characterist
featur
rapid
respons
infect
halt
lack
memori
function
schiller
et
al
innat
immun
system
may
includ
dendrit
cell
dc
macrophag
mast
cell
neutrophil
basophil
eosinophil
invari
natur
killer
cell
nk
cell
nkt
cell
gd
cell
comparison
adapt
immun
system
acquir
immun
respons
rel
slow
process
mediat
cell
b
cell
employ
divers
antigen
receptor
encod
germ
line
cell
rather
de
novo
gener
dna
rearrang
mechan
somat
immun
tissu
mammalian
organ
iwasaki
medzhitov
krogsgaard
davi
characterist
variou
immun
cell
type
involv
innat
adapt
immun
summar
fig
number
recent
find
focus
specif
cellular
function
well
complex
function
special
immun
cell
drastic
expand
knowledg
immun
medzhitov
et
al
vivier
et
al
exampl
nk
cell
origin
defin
effector
lymphocyt
innat
immun
endow
constitut
cytolyt
function
recent
studi
howev
disclos
nk
cell
also
mount
form
antigenspecif
immunolog
memori
vivier
et
al
therefor
nk
cell
may
also
classifi
new
type
immun
cell
exert
sophist
biolog
function
contribut
innat
adapt
immun
properti
render
adapt
immun
slow
respons
innat
immun
rapid
respons
fig
characterist
function
variou
innat
adapt
immun
cell
immun
system
immun
system
divid
innat
immun
adapt
immun
innat
immun
system
involv
particip
dendrit
cell
macrophag
mast
cell
granulocyt
neutrophil
eosinophil
basophil
nk
cell
nkt
cell
dg
cell
other
key
function
cell
type
describ
blue
grid
adapt
immun
system
involv
cell
cell
b
cell
other
cell
differenti
induc
treg
itreg
cell
differ
microenviron
special
interact
cytokin
chemokin
distinct
activ
specif
transcript
nk
cell
highli
specif
select
variou
cellular
function
therebi
abl
respond
broad
spectrum
antigen
new
find
increas
appreci
import
immun
system
led
past
two
decad
consider
effort
spent
understand
immun
respons
variou
immunerel
diseas
govern
modul
immuneassoci
diseas
includ
viral
bacteri
pathogenmedi
infecti
diseas
allerg
diseas
inflammatori
bowel
diseas
cancer
number
chronic
diseas
known
correl
inflamm
inflamm
probabl
vital
immun
respons
induc
noxiou
stimuli
condit
schmidschonbein
inflamm
underli
wide
varieti
physiolog
patholog
process
enabl
surviv
tissu
repair
tissu
infect
injuri
maintain
organ
bodi
homeostasi
medzhitov
inflamm
known
human
thousand
year
due
observ
experi
wound
tissu
infect
medzhitov
tradit
symptom
inflamm
character
five
cardin
sign
red
swell
heat
pain
well
disturb
function
medzhitov
typic
inflammatori
respons
compos
four
key
compon
inflammatori
induc
signal
initi
inflamm
special
sensor
detect
induc
inflammatori
mediat
induc
sensor
target
tissu
function
alter
inflammatori
mediat
effector
inflamm
medzhitov
compon
relationship
shown
fig
compon
present
multipl
form
combin
result
distinct
inflammatori
pathway
differ
type
pathway
trigger
given
physiolog
environment
condit
depend
natur
inflammatori
induc
therefor
understand
character
type
induc
key
issu
need
address
studi
inflamm
induc
inflamm
gener
broadli
classifi
exogen
factor
cell
respons
confirm
cytotox
virusinfect
cell
tumour
cell
treg
cell
gener
group
two
class
itreg
cell
natur
treg
ntreg
cell
regul
specif
immun
respons
especi
immun
toler
maintain
immun
homeostasi
abbrevi
thelper
type
thelper
type
thelper
type
treg
regulatori
cell
nk
natur
killer
cell
nk
cell
natur
killer
cell
mhcii
major
histocompat
complex
class
ii
tcr
cell
receptor
ifng
interferongamma
tgfb
transform
growth
factorbeta
develop
phytocompound
medicin
plant
endogen
tabl
medzhitov
medzhitov
exogen
induc
categor
two
subgroup
microbi
nonmicrobi
two
type
microbi
induc
pathogenassoci
molecular
pattern
pamp
virul
factor
pamp
defin
set
conserv
molecular
pattern
character
microorgan
given
class
medzhitov
janeway
pamp
defin
context
host
evolv
correspond
set
patternrecognit
receptor
prr
respons
detect
presenc
pamp
second
class
microbi
induc
compos
variou
virul
factor
henc
restrict
variou
pathogen
contrast
pamp
virul
factor
sens
directli
dedic
specif
receptor
exogen
induc
nonmicrobi
origin
includ
variou
allergen
irrit
foreign
fig
schemat
represent
inflammatori
pathway
inflammatori
pathway
consist
four
major
compon
induc
lipopolysaccharid
lp
sensor
tolllik
receptor
tlr
mediat
tumour
necrosi
factoralpha
tnfa
prostaglandin
nitric
oxid
effector
leukocyt
endotheli
cell
hepatocyt
other
medzhitov
medzhitov
varieti
allergen
sens
mimic
virul
activ
parasit
other
may
function
irrit
mucos
epithelia
inflammatori
respons
induc
type
induc
quit
similar
action
immun
system
parasit
environment
irrit
depend
mainli
expuls
clearanc
control
mucos
epithelia
sensor
allergen
howev
larg
unknown
essenc
endogen
induc
inflamm
defin
signal
produc
malfunct
stress
damag
cell
tissu
trigger
distinct
type
inflammatori
respons
suggest
play
vital
role
immun
respons
medzhitov
ident
featur
signal
current
well
defin
understood
howev
appar
belong
differ
function
class
specifi
accord
natur
level
cell
tissu
anomali
report
import
common
theme
univers
one
detect
acut
tissu
injuri
sens
desequestr
cell
organel
molecul
normal
maintain
separ
entiti
intact
undamag
cell
tissu
sequestr
activ
compon
includ
variou
ligand
receptor
enzym
provid
variou
type
compartment
normal
commonli
occur
normal
tissu
among
obviou
exampl
sequestr
bound
cellular
membran
basement
membran
surfac
epithelium
vascular
endothelium
medzhitov
exampl
necrot
cell
death
integr
plasma
membran
damag
result
releas
number
damp
constitu
includ
atp
uric
acid
k
ion
highmobl
group
box
protein
bianchi
anoth
class
endogen
induc
includ
crystal
monosodium
urat
calcium
pyrophosph
dihydr
advanc
glycat
end
product
age
correl
chronic
inflammatori
condit
specif
salt
crystal
induc
inflammatori
condit
gout
pseudogout
age
bind
advanc
glycat
endproductspecif
receptor
rage
also
known
ager
mediat
induct
inflamm
final
class
endogen
induc
breakdown
product
extracellular
matrix
ecm
gener
tissu
damag
malfunct
medzhitov
one
beststudi
compon
process
glycosaminoglycan
hyaluron
normal
condit
hyaluron
present
inert
highmolecularweight
polym
tissu
injuri
caus
breakdown
lowmolecularweight
fragment
induc
inflammatori
activ
via
activ
tolllik
receptor
result
tissuerepair
respons
jiang
et
al
medzhitov
key
convers
activ
regul
reactiv
oxygen
speci
ro
depend
signal
fact
number
endogen
pathway
initi
inflammatori
respons
known
depend
ro
activ
therefor
ro
consid
promis
target
immunomodul
antiinflamm
recent
find
spectrum
immunolog
scientist
medzhitov
medzhitov
medzhitov
et
al
increas
awar
inflamm
come
distinct
form
modal
regul
differ
molecular
cellular
mechan
induct
regul
resolut
undoubtedli
wellcontrol
inflammatori
respons
benefici
homeostasi
eg
provid
protect
tissu
injuri
pathogen
infect
howev
becom
detriment
dysregul
process
occur
eg
result
septic
shock
therefor
highli
import
govern
variou
dysregul
acut
inflammatori
disord
appropri
drug
specif
therapeut
interestingli
past
decad
research
focu
prevail
inflammatori
condit
shift
treat
acut
inflammatori
reaction
respons
infect
orand
tissu
wound
newli
defin
chronic
inflammatori
state
accompani
obes
type
diabet
atherosclerosi
asthma
cancer
variou
neurodegen
diseas
donath
shoelson
nguyen
casal
ouchi
et
al
therapeut
immunomodul
refer
therapeut
approach
interven
adjust
autoregul
immun
respons
desir
level
via
immunestimul
immunesuppress
induct
immunolog
toler
immunomodul
defin
substanc
agent
elicit
immunomodulatori
activ
alter
affect
immun
cell
system
produc
desir
immun
respons
dynam
regul
target
immun
system
spelman
et
al
immunomodul
tradit
divid
three
group
immunosuppress
agent
immunostimul
tolerogen
immunostimul
also
known
immunostimul
substanc
stimul
immun
system
induc
activ
augment
activ
immun
system
compon
usual
use
treatment
control
infect
immunodefici
cancer
immunosuppress
agent
also
known
immunosuppress
substanc
reduc
abil
immun
system
inhibit
activ
decreas
activ
compon
type
agent
often
use
organ
transplant
andor
autoimmun
diseas
tolerogen
recogn
induc
immunolog
toler
make
immun
system
nonrespons
target
antigen
immunolog
adjuv
consid
anoth
type
immunomodul
agent
stimul
immun
system
increas
respons
vaccin
without
possess
specif
antigen
effect
alon
variou
phytomedicin
found
modul
compon
inflammatori
pathway
includ
variou
induc
sensor
mediat
sensor
mention
base
understand
variou
immunomodul
activ
profound
effect
certain
tradit
medicin
activ
suggest
plantderiv
secondari
metabolit
natur
product
could
import
resourc
futur
develop
immunomodul
immunotherapi
take
treatment
allerg
diseas
exampl
immunomodul
aim
decreas
patholog
immun
respons
inflamm
instead
caus
unwant
return
immunolog
naiv
unrespons
state
nguyen
casal
basi
knowledg
innat
adapt
immun
respons
molecular
cellular
level
variou
immunomodul
number
allerg
diseas
includ
asthma
allerg
rhiniti
eosinophil
esophag
develop
akdi
et
al
chang
et
al
sever
approach
explor
immunomodul
activ
mous
model
allerg
diseas
effect
translat
use
result
human
clinic
trial
pleiotrop
natur
associ
relat
cytokineschemokin
underli
effector
mechan
vari
phenotyp
diseas
need
care
investig
develop
futur
treatment
diseas
common
goal
treat
diseas
decreas
excess
thelper
respons
via
variou
mechan
block
critic
cytokin
activ
inhibit
cytokin
synthesi
block
critic
effector
molecul
inhibit
key
celltyp
popul
involv
respons
stimul
respons
balanc
nguyen
casal
therapi
direct
specif
effector
molecul
includ
immunoglobulin
e
target
receptor
augment
balanc
promis
target
immunemodul
therapi
allerg
diseas
herbal
extract
ganoderma
lucidum
glycyrrhiza
radix
sophora
flavescenti
radix
found
reduc
eosinophil
infiltr
lung
inhibit
airway
hyperrespons
ahr
ovalbumin
ova
sensit
mice
via
reduc
level
ige
cytokin
increas
level
ifng
secret
buss
et
al
shen
et
al
addit
suppress
inflammatori
respons
import
approach
immunomodul
boost
individu
immun
defenc
system
give
either
physiolog
supraphysiolog
dosag
exogen
cytokin
therapeut
substanc
treat
associ
chronic
malign
viral
infect
nelson
ballow
studi
approach
consist
pathogenderiv
vaccin
tumour
cellbas
vaccin
dcbase
immunotherapi
peptid
vaccin
melief
smyth
et
al
number
clinic
studi
approach
demonstr
safeti
necessarili
satisfi
clinic
efficaci
experiment
medicin
robson
et
al
moreov
emerg
consensu
efficaci
therapi
activ
sever
specif
compon
immun
system
whelan
et
al
cancer
immunotherapi
use
cytokin
import
attract
approach
cancer
therapi
howev
optim
pharmacolog
dose
avoid
cytotox
reaction
remain
challeng
issu
chada
et
al
sever
cytotox
drug
paclitaxel
shown
also
confer
immunomodulatori
effect
rel
low
dose
exhibit
immunitydepend
cur
effect
anim
model
mizumoto
et
al
shin
et
al
combin
therapi
use
lowdos
anticanc
agent
cytokin
togeth
reveal
benefit
studi
also
shown
induc
thelper
th
cytokin
use
specif
adjuv
vital
enhanc
certain
antitumour
immun
therebi
prevent
reduc
tumour
growth
wen
et
al
therefor
develop
specif
phytocompound
herbal
medicin
immunomodulatori
agent
use
either
adjuv
therapeut
cancer
treatment
immunotherapi
emerg
clinic
issu
exampl
specif
phytocompound
dioscorea
batata
dscei
shown
increas
promot
activ
nuclear
factor
kappa
b
nfkb
induc
elam
gmcsf
promot
construct
protect
anim
certain
test
cancer
su
et
al
anoth
group
agent
shown
potenti
stimul
hematopoiet
recoveri
patient
suffer
cytopenia
result
diseaseor
therapyrel
bone
marrow
suppress
nelson
ballow
exampl
phytocompound
batata
dsceii
extract
use
differ
fraction
procedur
propos
adjuv
therapi
use
alongsid
chemotherapi
su
et
al
innat
immun
first
line
host
defenc
malign
transform
pathogen
infect
medzhitov
janeway
inflammatori
pathway
shown
fig
immun
cell
probabl
play
vital
role
compon
sensor
mediat
effector
therefor
explor
understand
role
variou
immun
type
immun
system
underli
mechan
interact
cell
relat
pathogenesi
immunerel
disord
critic
import
develop
immunotherapeut
immunomodul
agent
shown
fig
innat
immun
mechan
known
involv
immunomodul
orchestr
array
cell
includ
nk
cell
nkt
cell
gdt
cell
macrophag
granulocyt
neutrophil
eosinophil
basophil
dc
adapt
immun
creat
network
among
b
cell
cell
differenti
cell
includ
helper
cell
includ
cell
induc
regulatori
cell
itreg
cell
natur
regulatori
cell
differenti
thymu
immun
function
dysfunct
key
immun
cell
type
play
essenti
role
variou
immun
diseas
briefli
describ
among
cell
involv
innat
immun
dc
act
frontlin
cell
confer
phagocytosi
produc
cytokin
chemokin
invad
pathogen
also
special
profession
antigenpresent
cell
apc
uniqu
tcell
stimulatori
abil
play
vital
role
followup
adapt
immun
respons
immun
diseas
gener
apc
includ
dc
macrophag
b
cell
play
crucial
role
antigen
present
joffr
et
al
matur
encount
variou
danger
signal
initi
subsequ
immun
process
lead
activ
antigenspecif
tcell
respons
dc
well
known
key
immun
cell
highlight
award
half
nobel
prize
physiolog
medicin
ralph
steinman
discoveri
dc
role
adapt
immun
travi
steinman
demonstr
presenc
new
immun
cell
type
physiolog
dc
act
sentinel
peripher
tissu
encount
invad
pathogen
danger
signal
cours
infect
prr
dc
recogn
gener
pamp
microbi
signatur
enabl
dc
detect
molecular
speci
differ
pathogen
includ
bacteria
virus
bind
pamp
prr
dc
ligandreceptor
activ
instig
dc
activ
induct
matur
process
diebold
rei
e
sousa
matur
dc
perform
uptak
process
present
antigencontain
antigenexpress
materi
epitop
environ
mellman
steinman
immatur
dc
idc
usual
pick
foreign
materi
environ
ineffici
antigen
present
mellman
steinman
activ
antigen
process
present
ingest
materi
induc
dc
activ
undergo
matur
robson
et
al
particularli
sinc
recycl
molecul
passag
endosom
class
iirich
compart
ceas
upon
dc
activ
level
major
histocompat
complex
class
ii
mhcii
molecul
cell
surfac
elev
petersen
et
al
consequ
dc
increas
level
antigen
cell
surfac
impart
snapshot
antigen
deriv
target
pathogen
encount
infect
subsequ
dc
ceas
take
process
new
antigen
materi
environ
west
et
al
dc
matur
process
entail
chang
upregul
costimulatori
molecul
molecul
dc
surfac
act
matur
marker
increas
chemokin
receptor
express
level
scandella
et
al
express
accompani
inflammatori
mediat
prostaglandin
site
infect
enabl
dc
migrat
inflam
tissu
drain
lymph
node
scandella
et
al
arriv
drain
lymph
node
activ
dc
interact
cell
key
determin
dcderiv
signal
induc
interact
immun
respons
level
antigen
present
signal
express
level
costimulatori
molecul
signal
presenc
immunomodulatori
factor
specif
cytokin
signal
diebold
increas
level
antigen
present
express
costimulatori
molecul
dc
import
expans
antigenspecif
cell
wherea
suffici
induct
effector
function
diebold
immunomodulatori
factor
cytokin
signal
determin
differenti
expand
cell
effector
cell
sporri
rei
e
sousa
abil
dc
induc
differenti
effector
function
cell
enabl
immun
system
adjust
respons
combat
divers
class
pathogen
stimuli
shown
fig
differ
cytokin
express
pattern
dc
help
differenti
distinct
form
effector
cell
regulatori
cell
dysfunct
dc
involv
pathogenesi
varieti
immun
diseas
includ
type
diabet
rheumat
diseas
psoriat
arthriti
inflamm
microbi
infect
cancer
therefor
due
variou
uniqu
multifacet
featur
dc
promis
therapeut
target
skew
differenti
cell
treat
varieti
immun
diseas
especi
cancer
believ
spectrum
phytochem
deriv
plant
secondari
metabolit
tradit
medicin
may
applic
use
immunomodul
regul
variou
dc
function
instanc
show
phytocompound
mixtur
extract
butanol
fraction
bf
stem
leaf
l
extract
echinacea
purpurea
bf
lep
modul
dc
mobil
relat
cellular
physiolog
mous
immun
system
wang
et
al
yin
et
al
macrophag
key
player
innat
immun
system
fig
critic
effector
regul
inflamm
immedi
arm
immun
system
howev
also
confer
antigenpresent
abil
resid
cell
perform
phagocytosi
lymphoid
nonlymphoid
tissu
involv
steadyst
tissu
homeostasi
via
clearanc
cell
debri
apoptot
necrosi
cell
product
variou
growth
factor
geissmann
et
al
qian
pollard
macrophag
use
broad
rang
pathogenrecognit
receptor
ppr
becom
effici
phagocytosi
induc
product
proinflammatori
cytokin
time
effici
product
proinflammatori
cytokin
nitrogen
speci
well
extens
product
reactiv
oxygen
macrophag
may
serv
protect
mechan
differ
type
macrophag
recent
character
accord
function
particip
particular
immunolog
respons
qian
pollard
activ
macrophag
defin
cell
involv
respons
type
helper
cell
pathogen
bacteria
popul
activ
ifng
engag
tlr
characterist
elev
express
level
mhcii
product
tnfa
gener
nitric
oxid
ro
abil
kill
pathogen
undesir
stress
hostendogen
cell
contrast
altern
activ
macrophag
differenti
respons
play
key
role
respons
includ
wound
heal
humor
immun
qian
pollard
development
origin
function
tissu
macrophag
subset
divers
includ
microglia
dermal
macrophag
liver
macrophag
kupffer
cell
cell
remain
poorli
understood
qian
pollard
nonetheless
shown
play
import
role
sepsi
inflamm
liver
diseas
obes
cancer
qian
pollard
use
phytomedicin
immunomodulatori
agent
treat
macrophagerel
immun
diseas
may
promis
approach
develop
new
gener
therapeut
take
specif
phytocompound
exampl
show
shikonin
select
inhibit
express
tnfa
mrna
splice
level
chiu
yang
also
significantli
inhibit
earli
mrna
express
inflammatori
cytokin
includ
tnfa
chemokin
caffeic
acid
deriv
ethyl
caffeat
natur
phenol
compound
isol
biden
pilosa
plant
markedli
suppress
lipopolysaccharid
lp
induc
product
mrna
protein
express
induc
nitric
oxid
synthas
ino
product
raw
macrophag
significantli
inhibit
tpainduc
express
mous
skin
tissu
chiang
et
al
nk
cell
known
effector
lymphocyt
innat
immun
system
control
variou
type
tumour
growth
microbi
infect
mechanist
limit
spread
subsequ
tissu
damag
vivier
et
al
nk
cell
number
trait
common
cell
sun
et
al
recent
studi
shed
light
new
role
nk
cell
differ
immun
respons
suggest
innat
lymphocyt
characterist
innat
adapt
immun
cooper
et
al
vivier
et
al
activ
nk
cell
result
cytotox
cytokin
product
activ
may
trigger
disappear
class
mhc
molecul
cell
surfac
tumour
cell
exposur
antigen
mhc
class
irel
chain
b
mica
micb
ligand
express
induc
dna
damag
tumour
cell
phytochemicalderiv
medicin
may
prove
highli
use
resourc
develop
immunomodulatori
agent
control
nk
cell
activ
exampl
oral
administr
total
flavon
polysaccharid
epimedium
dose
mgkg
day
shown
significantli
enhanc
activ
nk
cell
age
rat
et
al
anoth
studi
indic
aqueou
extract
nigella
sativa
significantli
enhanc
nk
cytotox
activ
specif
cancer
cell
suggest
document
antitumour
effect
n
sativa
may
part
due
abil
stimul
nk
antitumour
activ
majdalawieh
et
al
natur
killer
cell
nkt
cell
lipid
antigenreact
immunoregulatori
lymphocyt
enhanc
cellmedi
immun
infecti
organ
bacteria
self
endogen
antigen
determin
tumour
godfrey
et
al
invari
natur
killer
inkt
cell
subset
ab
tcell
receptor
abtcr
cell
restrict
molecul
modul
activ
dc
cell
b
cell
increas
dcinduc
band
tcell
respons
inkt
cell
amplifi
tlrderiv
signal
thought
combin
specif
compound
activ
inkt
cell
may
provid
formul
could
serv
vaccin
adjuv
cerundolo
et
al
addit
inkt
cell
express
invari
tcell
receptor
chain
recogn
glycolipid
antigen
present
molecul
present
surfac
tumour
cell
allow
receptorligand
action
nkt
cell
subsequ
elicit
antitumour
effect
primarili
via
secret
ifng
directli
effect
cytotox
inkt
cell
recogn
uniqu
popul
cell
immunomodulatori
properti
link
innat
adapt
immun
respons
cerundolo
et
al
godfrey
et
al
adapt
immun
system
includ
two
major
type
lymphocyt
cell
b
cell
made
sever
subset
fig
b
cell
differenti
plasma
cell
secret
antibodi
lymphocyt
cell
divid
two
class
cell
cell
janeway
cell
differenti
cytotox
cell
kill
virusinfect
cell
tumour
cell
wherea
cell
differenti
differ
subset
cell
activ
cell
type
execut
specif
immun
function
b
lymphocyt
requir
induct
effect
antibodybas
immun
follow
pathogen
challeng
antibodi
respons
b
cellmedi
humor
immun
activ
thelper
cell
cell
current
avail
vaccin
mostli
develop
explor
specif
antibodi
produc
b
lymphocyt
protect
diseas
diphtheria
tetanu
hepat
measl
pneumococc
meningococc
infect
makela
phytocompound
phytochem
phytoextract
regul
blymphocyt
effector
function
potenti
employ
use
tool
mainten
protect
immun
howev
efficaci
specif
vaccin
current
limit
exampl
quan
et
al
report
intranas
coadministr
inactiv
influenza
viru
panax
ginseng
day
significantli
increas
level
influenza
virusspecif
igg
serum
compar
control
mice
possibl
due
high
saponin
content
studi
p
ginseng
shown
elev
mous
lung
iga
level
day
postchalleng
influenza
viru
suggest
phytochem
p
ginseng
appar
modul
system
mucos
immun
may
act
power
mucos
adjuv
vaccin
cell
cytotox
lymphocyt
ctl
potent
profession
killer
particularli
import
protect
virusinfect
cell
tumour
cell
report
suggest
one
singl
activ
ctl
cell
elimin
hundr
target
tumour
cell
previou
studi
also
show
oral
administr
cerevisiaederiv
bglucan
mice
elev
level
intraepitheli
lymphocyt
iel
comparison
control
mice
tzianabo
cell
major
orchestr
conductor
adapt
immun
respons
upon
interact
antigenpres
cell
dc
cell
differenti
varieti
effector
subset
includ
classic
thelper
cell
cell
well
recent
defin
cell
induc
regulatori
itreg
cell
describ
fig
differenti
determin
predominantli
specif
cytokin
present
microenviron
strength
interact
cell
antigen
receptor
target
antigen
sakaguchi
et
al
tradit
cell
produc
ifng
contribut
cellular
immun
intracellular
microorgan
bacteria
effect
produc
innat
immun
cell
dc
ifng
produc
cell
nk
cell
skew
polar
cell
toward
cell
differenti
action
box
transcript
factor
tbet
cell
produc
cytokin
essenti
humor
immun
control
infect
helminth
extracellular
pathogen
cell
differenti
attribut
action
occur
downstream
action
cell
produc
play
vital
role
clearanc
extracellular
fungi
bacteria
especi
mucos
immun
medzhitov
et
al
cell
differenti
mediat
retinoidrel
orphan
receptor
ror
gt
transcript
factor
activ
tgfb
combin
proinflammatori
cytokin
sakaguchi
et
al
regulatori
treg
cell
character
express
forkhead
box
gene
classifi
two
categori
itreg
cell
differenti
cell
natur
treg
ntreg
cell
aris
thymu
aberr
control
malfunct
cell
respons
may
contribut
organspecif
autoimmun
wherea
cell
contribut
atopi
allergi
asthma
treg
cell
play
crucial
role
regul
effector
cell
respons
therebi
prevent
bodi
potenti
pathogen
effect
sakaguchi
et
al
variou
phytochem
phytocompound
phytoextract
tradit
medicin
may
use
maintain
optim
immun
system
via
modul
differ
subset
helper
cell
instanc
tripterygium
wilfordii
hook
f
twhf
evalu
treat
autoimmun
diseas
includ
rheumatoid
arthriti
ra
triptolid
diterpen
purifi
plant
shown
inhibit
peripher
lymphocyt
increas
lymphocyt
peyer
patch
mice
collageninduc
mous
arthriti
model
zhou
et
al
five
medicin
herb
select
section
detail
review
long
histori
human
use
tradit
folk
medicin
echinacea
topsel
herbal
remedi
usa
use
tradit
medicin
nutraceut
usa
europ
decad
perhap
centuri
four
medicin
plant
extens
use
tcm
taiwanes
tradit
medicin
singl
herb
formul
herb
specif
indic
evid
accumul
seri
studi
group
wang
et
al
wang
et
al
yin
et
al
demonstr
immunomodulatori
activ
e
purpurea
lithospermum
erythrorhizon
batata
vitro
vivo
biolog
assay
system
use
transgen
omic
research
approach
artemisinin
artemisia
annua
recogn
benefit
use
treatment
malaria
dr
tu
recent
lasker
award
medic
research
find
relat
plant
tu
research
reveal
import
annua
phytochem
use
malaria
also
potenti
applic
inflammatori
diseas
tu
wilfordii
hook
f
tradit
use
treat
autoimmun
diseas
includ
ra
brinker
raskin
tao
et
al
one
wellknown
bioactiv
compon
triptolid
shown
possess
strong
immunosuppress
effect
potenti
treat
seri
autoimmun
diseas
echinacea
purpurea
echinacea
topsel
herbal
remedi
unit
state
claim
confer
high
immunostimulatori
activ
act
immunopromot
ernst
reput
allevi
respiratori
infect
cold
includ
sore
throat
cough
symptom
et
al
echinacea
angustifolia
echinacea
pallida
e
purpurea
three
major
speci
use
tradit
medicin
nutraceut
applic
unit
state
europ
borcher
et
al
common
constitu
echinacea
alkamid
caffeic
acid
deriv
shown
fig
polysaccharid
lipoprotein
pietta
et
al
activ
compon
present
echinacea
may
vari
due
differ
plant
age
organ
portion
agricultur
condit
geograph
locat
tissu
extract
method
perri
et
al
accumul
number
studi
report
effect
e
purpurea
perspect
immun
function
system
brush
et
al
mishima
et
al
frequent
report
pharmacolog
activ
echinacea
activ
macrophag
polymorphonuclear
neutrophil
immun
cell
goel
et
al
sullivan
et
al
recent
studi
shown
macrophag
phagocytosi
nk
cell
activ
strongli
activ
ex
vivo
exposur
cell
e
purpurea
extract
see
et
al
report
increas
macrophag
phagocyt
activ
mous
liver
spleen
follow
oral
administr
e
purpurea
extract
develop
phytocompound
medicin
plant
shown
result
enhanc
express
cytokin
includ
tnfa
product
rining
et
al
also
determin
e
purpurea
extract
enhanc
phagocyt
activ
human
peripher
blood
mononuclear
cell
rining
et
al
recent
sasagawa
et
al
found
low
concentr
ethanol
extract
obtain
aerial
portion
e
purpurea
suppress
abil
activ
cell
express
key
cytokin
involv
earli
phase
jurkat
tcell
activ
moreov
recent
studi
report
differenti
express
key
accessori
molecul
detect
polysaccharideenrich
e
purpurea
root
extract
ethanol
alkamidesenrich
e
purpurea
leaf
extract
benson
et
al
e
purpurea
root
extract
increas
express
mhc
class
ii
costimulatori
marker
proinflammatori
cytokin
tnfa
e
purpurea
leaf
extract
decreas
express
test
marker
cytokin
suggest
root
extract
leaf
extract
e
purpurea
plant
stimul
inhibit
immun
activ
respect
benson
et
al
similar
effect
also
observ
investig
immunomodulatori
effect
e
purpurea
extract
human
monocytederiv
dc
mous
bone
marrowderiv
dc
wang
et
al
wang
et
al
employ
chemic
defin
e
purpurea
extract
term
bf
lep
contain
hypoxanthin
chlorogen
acid
caffeic
acid
cichor
acid
galactosid
galactosid
rutin
index
compound
wang
et
al
find
suggest
bf
lep
phytochem
mixtur
abl
modul
cell
adhes
cell
mobil
cytokineand
nfkb
signallingrel
activ
primari
cultur
mous
dc
could
also
enhanc
mobil
dc
target
specif
lymphoid
tissu
test
mice
vivo
traffick
experi
yin
et
al
studi
perform
use
network
knowledgebas
approach
analys
genomewid
transcriptom
activ
vitro
vivo
correl
specif
proteom
activ
special
function
genom
phenotyp
test
cell
wang
et
al
wang
et
al
also
show
alkamid
play
import
role
antiinflammatori
activ
echinacea
reveal
compar
metabolom
approach
celland
genebas
assay
hou
et
al
possibl
receptor
cannabinoid
report
mediat
bioactiv
pleiotrop
effect
e
purpurea
manipul
endocannabinoid
system
molecular
target
receptor
endocannabinoid
transport
degrad
chicca
et
al
hohmann
et
al
harvest
medicin
herb
differ
region
differ
period
year
shown
play
role
quantiti
bioactiv
compon
found
plant
associ
pharmacolog
activ
jia
zhao
liu
et
al
e
purpurea
exampl
plant
extract
found
display
differenti
profil
vari
amount
phenol
compound
includ
caffeic
acid
cichor
acid
chlorogen
acid
alkamid
differ
season
month
plant
growth
andor
year
harvest
sometim
accord
differ
postharvest
treatment
hou
et
al
liu
et
al
sinc
phytochem
plant
bioactiv
compon
contribut
immunomodulatori
activ
e
purpurea
differenti
amount
compon
may
result
distinguish
biolog
effect
function
compar
genom
analysi
cellular
immunolog
effect
differ
antiinflammatori
phytoextract
phytocompound
especi
via
microarray
analysi
recogn
promis
approach
distinguish
complex
specif
bioactiv
candid
phytomedicin
wang
et
al
b
howev
combin
set
data
protein
express
proteom
western
blot
analys
critic
import
verif
transcriptom
result
exampl
wang
et
al
colleagu
investig
specif
differenti
gene
express
human
idc
respons
treatment
bf
contain
defin
bioactiv
phytocompound
extract
stem
leav
e
purpurea
denot
bf
lep
wang
et
al
b
result
affymetrix
dna
microarray
show
signific
upregul
specif
gene
cytokin
chemokin
within
h
bf
lep
treatment
idc
bioinformat
analysi
gene
express
bf
lep
treat
dc
show
key
signal
network
involv
number
immunomodulatori
molecul
possibl
lead
activ
downstream
molecul
adenyl
cyclas
confirm
proteom
analysi
result
also
show
upregul
antioxid
defenc
enzym
mnsod
downregul
cytoskelet
protein
cofilin
treatment
bf
lep
cichor
acid
data
verifi
western
blot
analys
b
dioscorea
batata
dioscorea
speci
wide
use
plant
eastern
tradit
medicin
also
modern
western
medicin
batata
yam
wide
distribut
east
asia
long
use
supplement
major
sourc
steroid
precursor
li
ni
prescrib
treat
poor
appetit
chronic
diarrhoea
asthma
frequent
uncontrol
urin
diabet
even
emot
instabl
hou
et
al
sever
activ
compon
tuber
batata
shown
exhibit
immunomodulatori
activ
oh
lim
su
et
al
phytochem
includ
mucopolysaccharid
dioscorin
diosgenin
fig
batatasin
glycoprotein
dioscorin
tuber
protein
shown
exhibit
system
mucos
immunomodulatori
activ
vivo
oral
administr
dioscorin
storag
protein
batata
tuber
enhanc
prolifer
cell
spleen
lin
et
al
dioscorin
also
act
activ
induc
macrophag
activ
via
typic
pathway
via
stimul
multipl
signal
molecul
nfkb
erk
jnk
induct
express
proinflammatori
cytokin
tnfa
fu
et
al
mucopolysaccharid
batata
significantli
increas
ifng
product
treat
splenocyt
suggest
may
induc
cellmedi
immun
respons
choi
et
al
besid
mucopolysaccharid
mgml
found
increas
uptak
capac
lysosom
phosphatas
activ
test
periton
macrophag
choi
et
al
batatasin
fig
wellidentifi
structur
shown
inhibit
gener
prostaglandin
leukotrien
degranul
activ
mous
bone
marrowderiv
mast
cell
lu
et
al
glycoprotein
batata
shown
inhibit
express
modul
mapk
mapk
mous
lymphocyt
lin
et
al
lead
possibl
glycoprotein
plant
may
use
appli
use
nutraceut
health
supplement
prevent
immun
disord
oh
lim
addit
dioscorea
glycoprotein
significantli
increas
traffick
macrophag
lymphocyt
neutrophil
monocyt
periton
caviti
huong
et
al
addit
signific
enhanc
prolifer
cell
b
cell
splenocyt
glycoproteintr
mice
nonspecif
cytolyt
activ
nk
cell
macrophag
significantli
increas
huong
et
al
glycoprotein
also
stimul
specif
immun
system
function
includ
macrophag
activ
via
increas
express
level
ino
tnfa
huong
et
al
previou
studi
found
fraction
batata
tuber
extract
significantli
increas
gmcsf
promot
activ
normal
inflam
skin
tissu
su
et
al
previou
studi
report
ethanolpartit
fraction
tuber
extract
batata
dsceii
may
confer
immunogen
activ
su
et
al
dsceii
contain
polysaccharid
high
abund
mannos
preferenti
promot
regener
cfugm
cell
damag
bone
marrow
tissu
su
et
al
dsceii
efficaci
level
bone
marrow
cell
restor
obtain
subcutan
administr
recombin
gcsf
protein
mgkg
mice
test
parallel
suggest
dsceii
fraction
batata
extract
may
use
develop
dietari
supplement
use
alongsid
chemotherapi
cancer
treatment
su
et
al
recent
also
obtain
result
indic
dscei
may
employ
adjuv
genebas
protein
subunit
cancer
vaccin
addit
ethanol
extract
bark
batata
identifi
confer
antiinflammatori
bioactiv
inhibit
ino
express
raw
cell
appar
via
nfkb
inactiv
jin
et
al
annua
ancient
chines
medicin
still
common
use
today
long
util
treat
malari
autoimmun
diseas
includ
system
lupu
erythematosu
ra
christen
veuthey
shown
fig
fig
chemic
structur
artemisinin
deriv
major
activ
compound
isol
annua
christen
veuthey
artemisinin
sesquiterpen
trioxan
lacton
chemic
structur
contain
peroxid
bridg
consid
critic
bioactiv
uniqu
among
antimalari
drug
van
agtmael
et
al
perspect
drug
metabol
artemisinin
primarili
convert
inact
metabolit
deriv
name
artesun
artelin
artemeth
arteeth
serv
parent
compound
exhibit
short
halflif
min
convert
highli
potent
activ
metabolit
dihydroartemisinin
dha
much
longer
halflif
h
balint
antimalari
mechan
artemisinin
shown
involv
interfer
parasit
transport
protein
disrupt
function
parasit
mitochondria
import
modul
host
immun
respons
function
golens
et
al
current
firstlin
antimalari
treatment
plasmodium
falciparum
recommend
world
health
organ
artemisinin
combin
therapi
reyburn
sever
therapeut
approach
develop
exampl
formul
one
artemisininderiv
phytochem
one
clinic
therapeut
antimalari
drug
combin
artemeth
lumefantrin
olliaro
taylor
artemisinin
also
report
suppress
lpsinduc
proteolyt
degrad
ikb
transloc
nfkb
thu
inhibit
ino
transcript
lead
blockad
synthesi
aldieri
et
al
artemisinin
artesun
dha
shown
enhanc
dna
synthesi
treatment
alloantigen
con
increas
product
mous
splenocyt
indic
artemisinin
deriv
may
select
promot
tcell
function
acceler
immun
reconstitut
activ
may
applic
futur
therapi
restor
immun
function
yang
et
al
artemisinin
also
report
inhibit
protein
express
unit
nfkb
mrna
express
nfkb
tgfb
level
tnfa
test
mice
lupu
nephriti
suggest
artemisinin
may
reliabl
effect
treatment
lupu
nephriti
artemisinin
also
reduc
angiotensin
iiinduc
cardiac
hypertrophi
via
inhibit
nfkb
bind
activ
mrna
express
level
tnfa
xiong
et
al
artemisinin
also
report
prevent
atherosclerosi
via
inhibit
activ
monocyt
recent
artemisinin
deriv
found
inhibit
gener
raw
mous
macrophag
cell
line
konkimalla
et
al
among
compound
studi
artesun
show
highest
inhibit
activ
microarray
analys
show
effect
artesun
macrophag
associ
mainli
metabol
signal
konkimalla
et
al
tripterygium
wilfordii
twhf
sometim
name
leigongteng
thunder
god
vine
chines
anoth
member
tradit
chines
pharmacopoeia
portion
twhf
plant
empir
tcm
use
debark
root
anecdot
use
treat
autoimmun
diseas
includ
ra
immun
complex
nephriti
system
lupu
erythematosu
organ
transplant
even
use
anticanc
agent
brinker
raskin
tao
et
al
start
seri
twhfassoci
product
claim
high
therapeut
valu
develop
patent
commerci
leigongteng
develop
multiglycosid
tablet
number
triterpen
diterpen
macrocycl
alkaloid
identifi
secondari
metabolit
twhf
plant
brinker
raskin
triptolid
c
h
diterpen
triepoxid
wellstudi
compon
deriv
twhf
first
recogn
diterpenoid
triepoxid
contain
abeoabietan
skeleton
shown
fig
kupchan
et
al
triptolid
report
exhibit
multipl
pharmacolog
activ
includ
antiinflammatori
krakauer
et
al
antineoplast
proapoptot
antonoff
et
al
antiangiogen
properti
triptolid
suppress
tlrinduc
nfkb
activ
downregul
trif
protein
premkumar
et
al
triptolid
also
amelior
chronic
coliti
disord
immun
state
mice
wei
et
al
triptolid
shown
suppress
nuclear
concentr
nfkb
secret
level
ifng
parallel
show
greater
potenc
cell
young
mice
oppos
older
mice
huang
et
al
addit
triptolidemedi
inhibit
lpsinduc
activ
nfkb
found
involv
downregul
express
result
impair
migrat
secondari
lymphoid
organ
test
dc
liu
et
al
triptolid
inhibit
staphylococc
exotoxinstimul
tcell
prolifer
express
tnf
ifng
human
pbmc
krakauer
et
al
previou
studi
show
triptolid
inhibit
secret
rant
tarc
lpsstimul
dc
result
impair
dcmediat
chemoattract
neutrophil
cell
vitro
vivo
test
condit
liu
et
al
triptolid
high
concentr
also
observ
induc
apoptosi
dc
sequenti
activ
map
kinas
phosphoryl
activ
liu
et
al
decreas
express
secret
cell
lead
impair
antigenpres
function
liu
et
al
jurkat
cell
triptolid
inhibit
phorbol
myrist
acet
pma
ionostimul
transcript
regul
purineboxantigen
receptor
respons
element
arr
nuclear
factor
activ
cell
nfat
nfkb
transcript
activ
qiu
et
al
function
genom
studi
triptolid
treatment
affect
express
immun
signal
gene
premkumar
et
al
shao
et
al
provid
evid
triptolid
could
significantli
attenu
tnfainduc
ino
nfkb
suppress
subsequ
product
human
ra
synovi
fibroblast
shao
et
al
triptolid
amelior
clinic
sign
experiment
autoimmun
encephalomyel
induct
heat
shock
protein
stabil
nfkbikba
transcript
complex
kizelsztein
et
al
triptolid
also
significantli
reduc
inflammatori
respons
cartilag
damag
joint
tissu
test
mice
collageninduc
arthriti
cia
appar
interf
ciainduc
express
matrix
metalloproteinas
mmp
augment
tissu
inhibitor
metalloproteinas
timp
triptolid
significantli
inhibit
gener
cell
murin
splenocyt
purifi
cell
dosedepend
manner
via
inhibit
transcript
mrna
phosphoryl
triptolid
effect
inhibit
express
ifngra
hacat
cell
hongqin
et
al
produc
antigenpres
cell
known
key
factor
gener
function
cell
respect
strongli
implic
pathogenesi
number
autoimmun
disord
triptolid
abl
inhibit
express
gene
transcript
level
part
activ
ccaatenhancerbind
proteina
cebpa
thu
inhibit
express
triptolid
activ
transcript
cebpa
enhanc
phosphoryl
critic
cebpa
inhibit
cebpa
activ
triptolid
depend
upstream
kinas
activ
triptolid
also
inhibit
migrat
lymphoma
cell
lymph
node
vitro
blockag
axi
triptolid
may
contribut
potenti
antimetastat
effect
zhang
et
al
triptolid
also
effect
block
induct
rna
matta
et
al
wilforlid
fig
anoth
tripterygium
glycosid
also
found
confer
efficaci
antiinflammatori
immun
suppress
activ
carrageenaninduc
rat
pedal
swell
tamponinduc
rat
granul
model
xue
et
al
dri
root
l
erythrorhizon
known
zicao
purpl
gromwel
refer
shikon
japanes
commonli
use
tradit
chines
herbal
medicin
china
taiwan
novoseltseva
et
al
use
thousand
year
treatment
macular
erupt
measl
smallpox
eczema
carbuncl
burn
novoseltseva
et
al
shikonin
deriv
primari
activ
compon
isol
root
tissu
tradit
chines
medicin
herb
l
erythrorhizon
recent
garner
consider
interest
broad
spectrum
antiinflammatori
activ
signific
antitumour
activ
chen
et
al
staniforth
et
al
su
et
al
chemic
structur
shikonin
deriv
shown
fig
section
focu
primari
activ
compound
shikonin
previou
studi
show
shikonin
drastic
suppress
transcript
activ
gmcsf
promot
inhibit
bind
tfiid
protein
complex
tata
box
su
et
al
addit
shikonin
effect
inhibit
promot
transcript
activ
proinflammatori
cytokin
tnfa
staniforth
et
al
interestingli
rel
low
concentr
mm
shikonin
also
specif
block
splice
tnfa
premrna
chiu
yang
shikonin
confer
drastic
acut
effect
human
monocyt
genom
proteom
level
demonstr
shikonin
significantli
inhibit
earli
express
within
h
approxim
gene
notabl
cytokin
tnfa
chemokin
inflammatori
modul
previou
studi
other
shown
shikonin
possess
multipl
pharmacolog
properti
antitumour
min
et
al
antioxid
antiplatelet
ko
et
al
antiatherosclerosi
activ
recent
report
antitumour
effect
shikonin
may
due
induct
ro
chang
et
al
mao
et
al
inhibit
proteasom
activ
yang
et
al
circumvent
cancer
drug
resist
via
induct
necroptosi
han
et
al
shikonin
also
consid
potenti
drug
treat
allerg
diseas
inhibit
pma
campinduc
express
downregul
express
maf
shikonin
significantli
prolong
surviv
recov
increas
number
cell
long
et
al
studi
suggest
antiinflammatori
effect
shikonin
may
due
proteasom
inhibitori
activ
result
accumul
ikba
ubiquitin
protein
blockag
transloc
cytoplasm
nucleu
shikonin
also
shown
induc
apoptosi
cell
death
rat
primari
macrophag
cultur
lu
et
al
report
reveal
woundheal
activ
shikonin
could
result
activ
prolifer
fibroblast
increas
collagen
fibr
level
granuloma
tissu
increas
cell
popul
granul
tissu
kaith
et
al
sakaguchi
et
al
accumul
evid
show
shikonin
may
serv
natur
occur
lowmolecularweight
panchemokin
receptor
inhibitor
chen
et
al
chen
et
al
chiu
et
al
chen
et
al
find
collect
strongli
suggest
shikonin
may
confer
spectrum
cellular
molecular
activ
induc
specif
chemokin
subsequ
chemotaxi
activ
variou
specif
immunerespons
cell
type
recent
shown
shikonin
may
involv
inhibit
acetylcholineinduc
aorta
relax
respons
gener
raw
cell
yoshida
et
al
shikonin
also
downregul
express
subsequ
express
pparg
cebpa
result
downregul
lipid
metabol
enzym
reduc
fat
accumul
lee
et
al
shikonin
effect
suppress
matur
ova
thymic
stromal
lymphopoietininduc
bone
marrow
dc
vitro
via
downregul
tnfa
inhibit
allerg
inflamm
ahr
murin
model
asthma
lee
et
al
addit
shikonin
may
also
evalu
potenti
therapeut
effect
allerg
asthma
block
histamin
releas
human
basophil
via
suppress
sykdepend
phosphoryl
inhibit
leukotrien
acid
takanoohmuro
et
al
shikonin
also
significantli
inhibit
express
upregul
mice
cia
suggest
shikonin
could
develop
candid
cartilag
protect
medicin
ra
dai
et
al
kim
et
al
natur
productderiv
medicin
trace
back
year
western
medicin
rel
short
histori
hundr
year
goldman
review
baluna
et
al
state
medicin
use
plant
speci
document
worldwid
baluna
kinghorn
also
estim
peopl
world
mostli
develop
countri
reli
herbal
medicin
treatment
variou
diseas
includ
immun
diseas
licciardi
underwood
moreov
approxim
fdaapprov
drug
deriv
botan
origin
licciardi
underwood
onaga
base
evid
import
investig
chemic
structur
tradit
phytomedicin
evalu
use
immunomodulatori
agent
immun
disord
provid
exampl
phytocompound
whose
specif
chemic
structur
immunomodul
activ
elucid
repres
phytocompound
chemic
structur
molecular
target
associ
diseas
summar
polyphenol
phenol
defin
substanc
aromat
ring
one
hydroxyl
substitu
includ
function
deriv
ester
glycosid
etc
shahidi
et
al
polyphenol
food
natur
health
product
origin
one
main
class
plant
secondari
metabolit
deriv
tyrosin
phenylalanin
fraga
shahidi
et
al
stilben
phenol
compound
consist
two
aromat
ring
link
ethen
bridg
lamoralthey
et
al
resveratrol
trihydroxystilben
well
known
kind
phytoalexin
belong
stilben
class
tabl
ii
compon
grape
berri
tcm
polygonum
cuspidatum
known
mediat
effect
modul
mani
differ
pathway
harikumar
aggarw
resveratrol
shown
bind
wide
rang
inflammationrel
cellsignal
molecul
harikumar
aggarw
wood
et
al
also
shown
regul
variou
transcript
factor
eg
nuclear
factor
erythroidderiv
nfk
b
activ
signal
transduc
activ
bcatenin
peroxisom
proliferatoractiv
receptorgamma
pparg
inhibit
activ
protein
kinas
eg
jnk
akt
induc
express
antioxid
enzym
eg
catalas
superoxid
dismutas
sod
inhibit
express
inflammatori
biomark
eg
ino
creactiv
protein
crp
tnfa
inhibit
express
metastat
angiogen
gene
eg
mmp
vascular
endotheli
growth
factor
vegf
cathepsin
intercellular
adhes
harikumar
aggarw
number
anim
studi
demonstr
polyphenol
hold
promis
use
varieti
ageand
inflammationassoci
diseas
includ
cancer
diabet
alzheim
diseas
cardiovascular
pulmonari
diseas
well
age
richard
et
al
curcumin
diferuloylmethan
diferuloyl
deriv
contain
carbon
atom
major
pigment
isol
curcuma
longa
zingiberacea
ginger
famili
tabl
ii
aggarw
curcumin
long
use
part
daili
diet
asian
countri
without
toxic
ammon
wahl
also
use
food
preserv
drug
yellow
colour
agent
compon
cosmet
probabl
studi
highli
pleiotrop
molecul
antiinflammatori
antioxid
antimetabol
chemoprevent
chemosensit
radiosensit
activ
goel
aggarw
gupta
et
al
lamoralthey
et
al
activ
c
longa
may
due
modul
factor
transcript
level
eg
nfkb
interfer
protein
kinas
eg
pkca
jnk
akt
enhanc
express
antioxid
enzym
eg
suppress
express
inflammatori
biomark
eg
ino
tnfa
inhibit
metastat
angiogen
gene
express
eg
vegf
aggarw
goel
aggarw
yadav
aggarw
multipl
activ
curcumin
meant
come
thought
somewhat
magic
bullet
target
broad
spectrum
diseas
includ
asthma
allergi
arthriti
atherosclerosi
heart
diseas
alzheim
diseas
diabet
metabol
syndrom
carrol
et
al
kanai
et
al
sharma
et
al
alreadi
enter
clinic
trial
cancer
treatment
phase
ii
level
past
year
bayetrobert
et
al
carrol
et
al
kanai
et
al
anoth
hydrocinnam
acid
deriv
also
show
similar
pattern
activ
curcumin
tabl
ii
kim
et
al
lee
et
al
park
et
al
flavonoid
one
abund
natur
occur
compound
ubiquit
vascular
plant
gome
et
al
almost
plant
tissu
synthes
flavonoid
pan
et
al
least
natur
occur
flavonoid
found
pan
et
al
flavonoid
character
basic
backbon
carbon
atom
gome
et
al
accord
chemic
structur
gener
categor
seven
group
flavon
flavanon
flavonol
flavanonol
isoflavon
flavanol
anthocyanidin
gome
et
al
usual
exist
form
aglycon
form
flavonoid
glycosid
flavonoid
glycosid
mainli
distribut
leav
flower
fruit
aglycon
appear
mainli
woodi
tissu
seed
may
contain
flavonoid
aglycon
glycosid
addit
wellknown
antioxid
activ
flavonoid
long
report
possess
antiinflammatori
antihepatotox
antiatherogen
antiosteoporot
antiallerg
anticanc
activ
gome
et
al
provid
two
exampl
flavonoid
shown
tabl
ii
quercetin
flavonol
found
grape
tea
onion
appl
leafi
green
veget
epigallocatechingal
egcg
potent
antioxid
recogn
activ
compon
tea
shown
tabl
ii
potent
antioxid
antiinflammatori
agent
protect
human
bodi
harm
effect
induc
free
radic
conforti
menichini
also
modul
phase
phase
ii
enzym
bacon
et
al
antiinflammatori
mechan
action
quercetin
egcg
believ
inhibit
transcript
factor
eg
nfkb
enhanc
result
reduct
proinflammatori
mediat
conforti
menichini
fraga
shahidi
et
al
featur
compound
evalu
develop
therapi
inflammationrel
diseas
age
neurodegen
diseas
inflammatori
bowel
diseas
cancer
diabet
among
natur
product
phenol
compound
terpenoid
major
phytochem
present
veget
fruit
dietari
medicin
food
salminen
et
al
terpenoid
compos
fivecarbon
isopren
unit
c
h
also
often
name
isoprenoid
de
la
hera
hortelano
basi
biosynthesi
chemic
structur
terpenoid
divid
five
subgroup
monoterpenoid
carbon
sesquiterpenoid
carbon
diterpenoid
carbon
triterpenoid
carbon
carotenoid
carbon
salminen
et
al
monoterpenoid
gener
form
two
isopren
unit
molecular
formula
c
h
usual
present
natur
acycl
monocycl
bicycl
form
modifi
oxid
methyl
glycosyl
bouvier
et
al
monoterpen
volatil
natur
monoterpen
employ
human
use
sinc
antiqu
monoterpen
limonen
fig
origin
obtain
citru
fruit
cherri
apricot
shown
suppress
nfkb
activ
berchtold
et
al
geniposid
fig
major
ingredi
fruit
gardenia
jasminoid
tradit
herbal
medicin
use
treat
inflamm
fever
headach
hepat
disord
inhibit
nfkb
ino
express
sesquiterpen
gener
defin
substanc
consist
three
isopren
unit
form
mono
bior
tricycl
compound
salminen
et
al
mani
tradit
natur
remedi
herbal
medicin
contain
sesquiterpenoid
modifi
structur
rearrang
sesquiterpen
structur
present
sesquiterpen
structur
identifi
character
howev
sesquiterpen
lacton
recogn
frequent
found
natur
robl
et
al
sesquiterpen
lacton
often
found
exhibit
potenti
medicin
properti
includ
chemoprevent
certain
inflammatori
diseas
cancer
robl
et
al
salminen
et
al
recent
number
studi
suggest
sesquiterpen
lacton
develop
therapeut
certain
diseas
lee
et
al
miller
su
shyur
et
al
among
artemisinin
fig
probabl
well
known
artemisinin
isol
leav
annua
tradit
chines
medicin
plant
tu
see
section
iiic
artemisinin
use
effect
antimalari
drug
especi
multidrugresist
malaria
artemisinin
deriv
also
shown
confer
antifung
anticanc
antiangiogenesi
immunosuppress
properti
cui
su
miller
su
nfkb
transcript
signal
system
suggest
target
mode
mechanist
action
artemisinin
result
strong
inhibit
inflamm
exampl
sesquiterpen
lacton
elephantopin
deriv
fig
includ
isodeoxyelephantopin
deoxyelephantopin
isol
elephantopu
scaber
plant
ichikawa
et
al
isodeoxyelephantopin
deoxyelephantopin
shown
possess
antiinflammatori
activ
also
confer
anticanc
activ
via
suppress
nfkb
activ
ichikawa
et
al
su
et
al
diterpen
consist
four
isopren
unit
basic
structur
c
h
ajikumar
et
al
robl
et
al
diterpenoid
gener
modifi
structur
rearrang
diterpen
structur
may
acycl
gener
present
mono
bi
tri
tetraor
macrocycl
compound
ajikumar
et
al
oleoresin
conif
plant
speci
usual
contain
number
diterpenoid
salminen
et
al
tradit
clinic
diterpenoidcontain
medicin
appli
varieti
diseas
includ
arthriti
atherosclerosi
cancer
inflamm
salminen
et
al
thoppil
bishaye
physiolog
typic
activ
diterpenoid
includ
retinol
deriv
taxan
phorbol
forskolin
gibberellin
pan
ho
retinoid
includ
alltransretino
acid
retinol
reput
play
essenti
role
function
mainten
human
vision
pan
ho
anoth
wellknown
exampl
taxol
complex
polyoxygen
diterpenoid
origin
bark
pacif
yew
tree
taxu
brevifolia
potent
anticanc
drug
clinic
use
treat
number
cancer
diseas
gener
name
paclitaxel
two
major
bioactiv
diterpenoid
deriv
tcm
reput
use
treat
variou
inflammatori
diseas
triptolid
fig
origin
isol
twhf
tanshinon
iia
fig
major
activ
diterpen
quinon
root
salvia
miltiorrhiza
miltiorrhiza
common
tcm
herb
use
treat
immunolog
disord
cardiovascular
diseas
osteoporosi
breast
cancer
gao
et
al
yuan
et
al
studi
shown
tanshinon
iia
inhibit
nfkb
signal
associ
inflammatori
mediat
gao
et
al
anoth
seri
diterpenoid
contain
specif
chemic
structur
abietan
type
also
found
potent
immunomodul
potenti
applic
broad
spectrum
diseas
prevent
block
induc
exogen
pathogen
initi
inflammatori
pathway
may
taken
approach
prevent
specif
immun
respons
exampl
sever
acut
respiratori
syndrom
sar
caus
infect
coronaviru
sar
coronaviru
sarscov
character
cytokin
storm
host
follow
infect
lead
seriou
damag
human
bodi
skowronski
et
al
previou
studi
show
diterpenoid
abietanetyp
diterpenoid
labdanetyp
diterpenoid
fig
suppress
sarscov
replic
henc
suggest
could
evalu
use
antivir
agent
wen
et
al
anoth
two
abietanetyp
diterpenoid
carnosol
carnos
acid
found
high
abund
rosemari
extract
rosmarinu
officinali
frequent
use
tradit
herbal
remedi
salminen
et
al
compound
possess
antioxid
antiinflammatori
activ
probabl
via
induct
express
inhibit
activ
nfkb
signal
pan
ho
salminen
et
al
lin
et
al
also
report
abietanetyp
diterpenoid
hdh
fig
isol
stem
bark
cryptomeria
japonica
suppress
tumour
growth
prostat
cancer
pca
xenograft
mice
base
variou
divers
bioactiv
abietanetyp
diterpenoid
addit
research
effort
may
need
focu
classifi
specif
subgroup
exampl
regard
whether
suppress
enhanc
nfkb
signal
directli
indirectli
serv
inflammationmodulatori
agent
immunestimulatori
agent
depend
structureact
relationship
instanc
taxol
report
activ
nfkb
signal
via
receptor
complex
tsuda
et
al
diterpenoid
mention
carnosol
possess
antiinflammatori
therapeut
effect
taken
togeth
find
suggest
diterpenoid
may
serv
group
promis
candid
drug
develop
triterpen
compos
isopren
unit
carbon
natur
occur
triterpenoid
cyclic
structur
ajikumar
et
al
libi
et
al
triterpenoid
synthes
mani
plant
cycliz
squalen
wide
use
variou
tradit
folk
medicin
phillip
et
al
celastrol
quinon
methid
pentacycl
triterpenoid
extract
tcm
twhf
report
possess
antioxid
antiinflammatori
anticanc
activ
pinna
et
al
celastrol
may
act
part
suppress
nfkb
signal
inhibit
inflamm
tumour
growth
kim
et
al
pinna
et
al
ursol
acid
differ
type
pentacycl
triterpen
main
activ
ingredi
tradit
herbal
remedi
rosemari
leav
liu
shown
fig
ursol
acid
well
known
possess
broad
spectrum
biolog
function
counteract
exogen
endogen
biolog
stimuli
ikeda
et
al
addit
report
confer
variou
medicin
effect
includ
antihyperlipidaemia
anticanc
hepatoprotect
activ
ikeda
et
al
pan
ho
salminen
et
al
report
inhibit
nfkb
activ
contribut
suppress
lpsinduc
proinflammatori
mediat
mous
macrophag
tpainduc
skin
tumour
promot
ikeda
et
al
et
al
show
ursol
acid
also
induc
nfkb
activ
result
releas
proinflammatori
mediat
nonstimul
mous
macrophag
therefor
specul
depend
biolog
statu
test
cell
tissu
ursol
acid
may
exert
contrast
antiand
proinflammatori
activ
ikeda
et
al
lupanetyp
triterpenoid
betulin
acid
deriv
fig
also
consid
therapeut
potenti
pathogen
infect
eg
hiv
cancer
eg
melanoma
differ
type
inflamm
fulda
takada
aggarw
also
observ
betulin
acid
inhibit
activ
ikka
nfkb
induc
variou
nfkb
activ
takada
aggarw
previou
studi
show
betulin
acid
confer
antisarscov
activ
wen
et
al
lupeol
similar
chemic
structur
betulin
acid
one
major
constitu
number
common
veget
fruit
medicin
herb
salminen
et
al
studi
possibl
therapeut
effect
specif
cancer
siddiqu
saleem
inflammatori
disord
fernandez
et
al
saleem
shown
inhibit
nfkb
signal
via
phosphoryl
ikba
protein
nfkbdepend
report
gene
activ
dna
bind
nfkb
complex
saleem
et
al
lupeol
appar
also
inhibit
signal
pathway
aktdepend
pathway
activ
may
contribut
variou
anticanc
antiinflammatori
properti
fernandez
et
al
salminen
et
al
carotenoid
known
pigment
tetraterpen
typic
contain
polyen
chain
deriv
eight
isopren
unit
conjug
doubl
bond
provid
strong
light
absorpt
brilliant
colour
allow
take
excess
energi
molecul
nonradi
energi
transfer
mechan
pan
ho
salminen
et
al
carotenoid
natur
occur
fatsolubl
pigment
give
bright
colour
host
plant
anim
plant
carotenoid
play
essenti
role
mainten
human
health
salminen
et
al
serv
power
antioxid
reput
allevi
sever
chronic
diseas
cardiovascular
diseas
osteoporosi
cancer
carotenoid
bcaroten
lutein
lycopen
also
offer
protect
inflammatori
respons
possibl
via
modul
redoxsensit
signal
pathway
nfkb
ro
signal
chew
park
de
stefano
et
al
huang
et
al
bcaroten
fig
common
cyclic
tetraterpen
potent
provitamin
natur
pan
ho
store
liver
convert
vitamin
lipophil
xanthophyl
lutein
fig
dihydroxi
deriv
bcaroten
wide
present
varieti
fruit
veget
well
egg
yolk
protect
oxid
stress
prevent
agerel
macular
degener
exhibit
neuroprotect
effect
retin
inflamm
sasaki
et
al
anoth
acycl
tetraterpen
lycopen
fig
abund
carotenoid
present
human
bodi
salminen
et
al
present
mainli
redcolour
veget
fruit
lycopen
power
antioxid
potent
vitamin
e
thu
prevent
cell
free
radic
attack
oxid
stress
also
claim
reduc
risk
variou
chronic
diseas
cardiovascular
diseas
ra
atherosclerosi
pan
ho
salminen
et
al
carotenoid
exhibit
antioxid
activ
may
warrant
futur
develop
immunomodul
organosulphur
compound
special
type
phytocompound
found
variou
allium
speci
organosulphur
compound
garlic
known
differ
slightli
onion
varieti
consequ
may
differ
health
benefit
two
major
kind
organosulphur
compound
present
onion
varieti
especi
garlicgglutamylscystein
cystein
sulphoxid
ca
alliin
raw
garlic
clove
crush
chop
chew
enzym
known
alliinas
releas
alliinas
catalys
format
sulphen
acid
cystein
sulphoxid
fig
sulphen
acid
spontan
react
form
unstabl
thiosulphin
compound
case
alliin
result
sulphen
acid
react
form
thiosulphin
halflif
crush
garlic
day
lawson
et
al
thiosulphin
format
rapid
complet
within
crush
garlic
clove
allicin
break
form
varieti
fatsolubl
organosulphur
compound
includ
diallyl
trisulphid
dat
diallyl
disulphid
dad
diallyl
sulphid
da
presenc
oil
organ
solvent
ajoen
vinyldithiin
block
watersolubl
organosulphur
compound
sallylcystein
sac
form
gglutamylcystein
longterm
incub
crush
garlic
aqueou
solut
manufactur
matur
garlic
extract
fig
oilsolubl
organosulphur
compound
allicin
easili
transform
oilsolubl
polysulphid
mostli
dad
da
dat
also
diallyl
tetrasulphid
fig
chemic
composit
variou
prepar
obtain
extract
oilsolubl
garlic
fraction
also
depend
specif
extract
condit
temperatur
treatment
time
interv
solvent
polar
analysi
allicin
solut
allow
stand
room
temperatur
h
show
follow
bioorgan
composit
dad
dat
da
diallyl
tetrasulphid
variou
find
suggest
higher
polysulphid
diallyl
penta
hexaor
hepta
sulphid
form
ogara
et
al
extract
condit
optim
allicin
transform
vinyldithiin
structur
zor
eajoen
type
vinyldithiin
compound
first
identifi
ga
chromatograph
analysi
product
thermal
degrad
allicin
brodnitz
et
al
lee
et
al
structur
form
dimer
thioacrolein
creat
via
allicin
belimin
ajoen
gener
via
allicin
sthiolat
acid
addit
origin
ajoen
isol
ether
fraction
garlic
extract
potenti
antithrombot
agent
block
et
al
reaction
allicin
group
yield
sac
sallylmercaptocystein
samc
watersolubl
organosulphur
compound
rabinkov
et
al
unlik
oili
sulphur
compound
watersolubl
compound
odourless
delic
less
characterist
flavour
kodera
et
al
phytocompound
form
aqueou
garlic
extract
initi
compound
gglutamylsallylcystein
gsac
transform
sac
reaction
catalys
gglutamyltranspeptidas
ggt
fig
sac
along
deriv
smethylcystein
smc
samc
compon
aqueou
extract
garlic
possess
variou
biolog
activ
vitro
vivo
condit
garlicand
onionderiv
organosulphur
compound
shown
suppress
vitro
activ
inflammatori
enzym
cyclooxygenas
lipoxygenas
ali
et
al
inhibit
express
ino
inflammatori
white
blood
cell
macrophag
dirsch
et
al
organosulphur
compound
shown
inhibit
express
inflamm
signal
molecul
cultur
macrophag
human
peripher
blood
mononuclear
cell
variou
find
demonstr
garlic
extract
deriv
compound
exhibit
antiinflammatori
effect
inhibit
nfkb
activ
induc
variou
receptor
agonist
includ
tnfa
lp
keiss
et
al
express
ino
also
shown
inhibit
garlic
extract
activ
macrophag
dirsch
et
al
liu
et
al
addit
youn
et
al
demonstr
garlic
extract
modul
inflammatori
respons
suppress
tlr
activ
type
bioactiv
polysaccharid
identifi
natur
product
accord
broad
divers
sourc
mainli
divid
five
categori
includ
higher
plant
fungal
polysaccharid
bacteri
lichen
alga
cheung
et
al
polysaccharid
one
main
class
variou
bioactiv
substanc
present
variou
tradit
herbal
medicin
shown
implic
confer
spectrum
pharmacolog
activ
especi
immunomodulatori
antitumour
effect
cancer
chemoprevent
effect
guo
et
al
unfortun
howev
immunoregulatori
activ
term
molecular
cellular
mechan
gener
well
understood
accord
similar
differ
chemic
structur
plant
polysaccharid
roughli
categor
sever
group
includ
b
dglucan
fig
dglucan
fig
blink
backbon
bbranch
fig
acetyl
glucomannan
fig
sulphat
polysaccharid
arabinan
fig
arabinogalactan
arabinogalactan
ii
fig
rhamnogalacturonan
rgi
fig
rg
ii
fig
pectin
fig
larg
volum
studi
report
variou
plant
polysaccharid
confer
potent
immunomodulatori
activ
regul
specif
function
variou
immun
cell
includ
monocyt
macrophag
nk
cell
dc
lymphocyt
b
lymphocyt
other
chen
et
al
thakur
et
al
zhang
et
al
recogn
distinguish
correspond
receptor
specif
immun
cell
tabl
iii
activ
immun
cell
gener
seri
specif
cellular
molecular
event
includ
innat
immun
acquir
immun
accumul
evid
shown
dc
potent
apc
major
immunomodulatori
target
polysaccharid
regul
innat
well
acquir
immun
kim
et
al
li
et
al
polysaccharid
increas
express
mhc
class
ii
costimulatori
molecul
variou
polysaccharid
affect
morpholog
matur
dc
upregul
gmcsf
downregul
phagocytosi
antigen
uptak
activ
dc
promot
dc
differenti
jeurissen
et
al
khayrullina
et
al
chen
et
al
find
show
polysaccharid
may
employ
potent
adjuv
design
efficaci
dcbase
vaccin
report
specif
extract
isol
root
echinacea
contain
high
quantiti
polysaccharid
shown
confer
strong
immunostimulatori
activ
activ
dc
matur
benson
et
al
variou
plant
polysaccharid
also
shown
affect
anoth
apc
type
macrophag
activ
suggest
involv
direct
elimin
alien
pathogen
dyingdamag
cell
regul
variou
immun
effector
cell
wang
et
al
zhang
et
al
polysaccharid
activ
macrophag
secret
proinflammatori
cytokin
eg
tnfa
ifng
zheng
et
al
increas
product
ro
myeloperoxid
enhanc
activ
cytotox
choi
hwang
phagocytosi
zheng
et
al
cell
prolifer
su
et
al
addit
effect
polysaccharid
myeloidlineag
immun
cell
mainten
skew
balanc
report
sun
et
al
polysaccharid
also
promot
differenti
b
cell
han
et
al
product
igg
igm
nose
et
al
shown
specif
extract
batata
use
adjuv
dcbase
vaccin
detail
describ
section
iiib
su
et
al
boon
et
al
ernst
cassileth
use
complementari
altern
medicin
becom
gener
accept
public
becom
popular
cancer
patient
popul
western
countri
xu
et
al
tcm
one
complementari
altern
medicin
welldocu
theoret
framework
longestablish
practic
histori
immunerel
diseas
includ
autoimmun
diseas
cancer
cho
aspect
immunomodulatori
characterist
tcm
gener
categor
two
major
group
proinflammatori
activ
antiinflammatori
activ
investig
potenti
therapeut
applic
adjuv
treatment
cancer
autoimmun
diseas
respect
possibl
cellular
andor
molecular
mechan
herbal
medicin
potenti
applic
futurecurr
clinic
immunetherapi
immun
disord
shown
fig
fig
possibl
mechan
herbal
medicin
immun
system
number
possibl
cellular
andor
molecular
mechan
herbal
medicin
involv
regul
variou
immun
cell
depict
black
arrow
follow
differ
immunomodulatori
activ
specif
defin
herbal
medicin
may
employ
potenti
futurecurr
clinic
applic
immunotherapi
immun
disord
black
box
abbrevi
nk
natur
killer
cell
dc
dendrit
cell
tlr
tolllik
receptor
mr
mannos
receptor
sr
scaveng
receptor
ro
reactiv
oxygen
speci
ino
induc
nitric
oxid
synthas
qi
et
al
effect
chemotherapi
suppress
host
immun
function
may
fact
worsen
tolerogen
tumour
microenviron
orchestr
tumourassoci
macrophag
myeloidderiv
suppressor
cell
mdsc
regulatori
cell
treg
lead
escap
tumour
cell
form
immunosurveil
host
therefor
effect
break
invas
metastasi
tumour
microenviron
restor
immun
function
cancer
patient
one
challeng
issu
face
cancer
research
today
grow
evid
reveal
tcm
may
effect
support
enhanc
efficaci
cancer
chemotherapi
via
improv
certain
specif
cellular
immun
function
diminish
side
effect
complic
result
convent
cancer
therapi
xu
et
al
mdsc
identifi
myeloid
cell
lineag
cell
pan
et
al
critic
immun
cell
type
involv
mainten
tolerogen
tumour
microenviron
mdsc
produc
sever
immunosuppress
factor
eg
arginas
ino
ro
specif
cytokin
tgfb
lead
develop
treg
inhibit
innat
adopt
immun
subvert
immunosurveil
pan
et
al
creat
signific
impedi
elimin
malign
cell
curcumin
shown
inhibit
tumourigen
tumour
growth
expans
mdsc
activ
nfkb
mdsc
reduc
level
human
gastric
cancer
xenograft
model
mous
colon
cancer
allograft
model
curcumin
treatment
polar
mdsc
toward
phenotyp
increas
express
decreas
express
vivo
vitro
extract
two
chines
medicin
herb
name
astragalu
membranaceu
ligustrum
lucidum
exert
signific
antitumour
activ
via
abolit
tumourassoci
macrophag
suppress
rittenhous
et
al
icariin
major
activ
ingredi
herba
epimedii
demonstr
confer
antiinflammatori
effect
murin
innat
immun
cell
activ
human
pbmc
zhou
et
al
report
administr
icariin
significantli
reduc
percentag
mdsc
concomit
activ
differenti
dc
macrophag
lead
downregul
tnfa
product
may
result
decreas
express
inhibit
activ
akt
zhou
et
al
addit
mdsc
develop
treg
cell
tumour
microenviron
anoth
import
determin
efficaci
certain
cancer
immunotherapi
radix
glycyrrhiza
polysaccharid
reduc
treg
popul
express
treg
cell
upregul
cytokin
ratio
decreas
level
tgfb
increas
level
sera
hepatocarcinomabear
mice
recent
r
glycyrrhiza
also
shown
regul
cellular
immun
tumourbear
mice
decreas
proport
treg
cell
increas
spleen
lymphocyt
transform
ratio
li
et
al
addit
glycyrrhizin
isol
r
glycyrrhiza
shown
reduc
gener
suppressor
macrophag
enhanc
efficaci
adopt
transfer
therapi
allospecif
ctl
suzuki
et
al
sulphat
polysaccharideprotein
complex
gekko
swinhoni
guenther
tcm
found
confer
strong
bioactiv
restor
defect
biorheolog
characterist
dc
via
decreas
secret
dc
thu
modifi
tumour
microenviron
lycium
barbarum
polysaccharid
shown
confer
antitumour
activ
increas
number
cell
tumour
infiltr
lymphocyt
reliev
immunosuppress
respons
enhanc
antitumour
function
immun
system
et
al
bushen
gubiao
recip
tradit
chines
herbal
medicin
shown
improv
innat
immun
function
upregul
tlrnfkb
signal
pathway
adjust
immun
imbal
thelper
cell
th
reduc
activ
treg
enhanc
immun
respons
radix
astragali
astragalu
propinquu
huangqi
long
use
modul
function
lung
gastrointestin
system
promot
heal
reduc
fatigu
current
number
immunomodulatori
properti
astragalu
detect
includ
increas
express
interferon
tnf
activ
lymphocyt
nk
cell
macrophag
nalbantsoy
et
al
song
hu
polypeptid
extract
scorpion
venom
shown
inhibit
angiogenesi
activ
lewi
lung
cancer
may
due
decreas
level
angiogen
factorsfactor
viii
asma
test
tumour
microenviron
addit
singl
herb
plant
mention
mixtur
multipl
plant
formul
tcm
prepar
also
shown
confer
immunostimulatori
activ
multipl
plant
formul
repeatedli
document
tradit
chines
medicin
book
knowledg
experi
present
formul
also
may
provid
new
altern
therapi
approach
combin
chemotherapi
treatment
recent
interest
exampl
success
develop
formula
tcm
report
dr
c
cheng
ye
et
al
chines
medicin
formul
compos
four
medicin
herb
yen
et
al
zhang
huang
qin
dri
root
scutellaria
baicalensi
georgi
baishao
dri
root
paeonia
lactiflora
pall
gan
cao
dri
honeyfri
root
rhizom
glycyrrhiza
uralensi
fisch
glycyrrhiza
inflata
bat
glycyrrhiza
glabra
l
da
zao
dri
fruit
ziziphu
jujuba
mill
formul
shown
efficaci
use
adjuv
treatment
cancer
chemotherapi
approach
ye
et
al
found
reduc
chemotherapyinduc
gastrointestin
toxic
lam
et
al
use
adjuv
therapi
chemotherapi
use
capecitabin
yen
et
al
irinotecan
leucovorin
wang
et
al
advanc
colorect
cancer
kummar
et
al
pancreat
gastrointestin
malign
kummar
et
al
saif
et
al
yen
et
al
juzentaihoto
extract
prepar
mixtur
speci
medicin
plant
includ
angelica
sinensi
p
lactiflora
atractylod
macrocephala
poria
coco
cinnamomum
cassia
membranaceu
liqusticum
wallichii
g
inflata
rehmannia
glutinosa
saiki
prescript
long
tradit
use
anaemia
anorexia
extrem
exhaust
fatigu
saiki
shown
augment
antibodi
product
mitogen
activ
splenocyt
b
cell
anticomplementari
activ
activ
macrophag
oral
administr
yamada
buzhongyiqitang
anoth
tradit
herbal
formul
contain
pinellia
tuber
baicalensi
zingiberi
rhizoma
zizyphi
fructu
coptidi
rhizoma
g
radix
p
ginseng
report
enhanc
concomit
immun
tumour
develop
restor
antitumour
respons
effector
cell
tumourbear
mice
li
et
al
immunogen
chemotherapi
recent
emerg
interest
approach
base
abil
cytotox
compound
induc
immunogen
tumour
cell
death
character
chang
dangerassoci
molecular
pattern
includ
heat
shock
protein
calreticulin
glucoserel
protein
highmobl
group
protein
box
new
compel
anticanc
strategi
may
offer
good
therapeut
potenti
provid
direct
tumourkil
effect
also
restor
tumourspecif
immun
respons
prevent
tumour
recurr
ullrich
et
al
unfortun
current
limit
chemotherapeut
drug
shown
confer
pharmacolog
characterist
effect
reutil
tcm
well
phytochem
may
offer
great
valu
drug
discoveri
one
potenti
may
area
develop
immunogen
chemotherapi
laboratori
also
identifi
test
sever
phytochem
includ
shikonin
deriv
synthet
compound
aim
make
use
immunogen
cell
death
activ
autoimmun
diseas
group
ill
often
involv
multipl
organ
clinic
applic
autoimmun
diseas
appear
either
system
case
system
lupu
erythematosu
organ
specif
case
type
diabet
mellitu
activ
defect
apoptosi
immun
effector
cell
b
lymphocyt
macrophag
play
critic
role
pathogenesi
autoimmun
disord
current
therapi
autoimmun
diseas
often
recommend
combin
sever
diseasemodifi
antirheumat
drug
dmard
design
preserv
differ
immunomodulatori
mechan
limit
success
prevent
ra
joint
destruct
current
avail
dmard
develop
effect
less
toxic
dmard
urgent
need
two
commonli
prescrib
chines
antirheumat
herb
name
twhf
mention
section
iiid
tetrandrin
shown
preserv
antiinflammatori
immunosuppress
effect
tetrandrin
purifi
creeper
stephania
tetrandra
moor
bisbenzylisoquinolin
alkaloid
use
drug
china
decad
ho
lai
lai
immunosuppress
effect
tetrandrin
may
synergist
current
dmard
highlight
tetrandrin
potenti
candid
dmard
treatment
autoimmun
diseas
especi
ra
lai
centuri
ganoderma
fungu
also
name
ling
zhi
chines
regard
premium
remedi
number
diseas
extract
ganoderma
report
improv
surviv
rate
lupu
mice
decreas
amount
proteinuria
decreas
serum
level
antidsdna
autoantibodi
show
evid
decreas
perivascular
parenchyma
mononuclear
cell
infiltr
vital
organ
lai
et
al
extract
acanthopanax
gracilistylu
markedli
suppress
prolif
activ
human
peripher
blood
lymphocyt
stimul
mitogen
concanavalin
staphylococcu
aureu
cowan
mechan
ageinduc
suppress
lymphocyt
shown
involv
cell
cycl
arrest
stage
without
direct
cytotox
effect
age
also
suppress
alloantigenspecif
ctl
respons
et
al
ethanol
extract
celastru
aculeatu
merr
celastru
anoth
chines
herb
downmodul
sever
adjuv
arthriti
reduc
level
tong
moudgil
high
valu
tradit
herbal
medicin
specif
medicin
plant
deriv
phytochem
medicin
chemistri
studi
applic
recent
address
dr
tu
natur
medicin
tu
wonder
experi
discoveri
artemisinin
annua
plant
use
treatment
malaria
appropri
lasker
award
medic
research
elegantli
address
articl
wisdom
tradit
medicin
may
need
rerecogn
develop
futur
medicin
within
context
recent
studi
multipl
formul
tcm
consist
four
differ
medicin
plant
speci
instead
singl
phytochem
potenti
use
botan
drug
cancer
treatment
elegantli
demonstr
group
c
cheng
lam
et
al
recent
report
scienc
translat
medicin
highqual
experiment
result
obtain
metabolit
profil
antitumour
antiinflammatori
molecular
mechan
relat
clinic
studi
two
report
combin
exemplifi
high
interest
import
worldwid
research
medicin
plant
phytomedicin
renew
interest
herbal
medicin
phytochemistri
blindfold
complex
challeng
difficulti
redefin
readdress
empir
anecdot
featur
number
tradit
medicin
includ
tcm
ayurveda
instanc
even
though
laboratori
other
employ
function
genom
proteom
limit
metabolom
approach
attempt
defin
immunemodulatori
activ
e
purpurea
plant
extract
hou
et
al
wang
et
al
medicin
plant
new
find
although
help
explor
possibl
molecular
mechan
action
mode
key
immun
cell
type
result
still
abl
allow
us
demonstr
efficaci
exact
function
spectrum
e
purpurea
herbal
product
commerci
product
care
redefin
clinic
trail
studi
use
bioactiv
chemic
profilingdefin
phytoextract
phytochem
mixtur
may
help
requir
futur
effort
experiment
system
tool
system
biologyom
studi
increasingli
avail
applic
research
medicin
plant
effect
mammalian
bioactiv
research
approach
strategi
howev
necessarili
provid
addit
benefici
inform
improv
use
phytomedicin
due
complex
diseas
disord
bodi
normal
physiolog
system
therefor
avoid
categor
becom
overoptimist
unrealist
futur
prospect
scienc
technolog
develop
herbal
medicin
similar
problem
also
recogn
current
develop
new
chemic
drug
pharmaceut
industri
repeat
find
readili
detect
antioxid
antiinflamm
antitumour
effect
broad
spectrum
herbal
medicin
may
alway
serv
good
indic
effect
efficaci
test
herbal
remedi
phytochem
sinc
modest
level
bioactiv
may
simpli
repres
reduct
activ
big
spectrum
plant
primari
secondari
metabolit
common
result
may
often
lack
true
specif
detect
bioactiv
test
phytoextract
phytochem
overli
simplifi
casual
claim
potent
antiinflammatori
antitumour
activ
may
view
hype
harm
research
activ
gener
henc
need
care
avoid
natur
orand
appear
multipl
molecular
target
tradit
herbal
medicin
phytochem
may
true
may
uniqu
featur
herbal
medicin
mani
singl
chemic
compound
well
known
exhibit
effect
via
interact
multipl
molecular
target
token
multipl
plant
formul
often
prescrib
tcm
practic
may
alway
accur
view
aim
multipl
cellularmolecular
target
key
rational
behind
multipl
plant
tcm
formul
often
reflect
benefit
king
primari
drug
minist
secondari
drug
adjuv
bioavailabilitydeliveri
carrier
combin
therefor
could
quit
specif
toward
specif
target
conclus
observ
big
chang
phytomedicin
research
new
concept
tool
approach
becom
increasingli
avail
may
need
system
buildup
network
integr
collabor
data
databas
share
global
level
